Working Groups
Vaccinations
Update of the 2008 Recommendations
Vaccinations remain one of the most effective measures against infectious diseases. In the past, numerous infectious diseases, especially measles, mumps, rubella, poliomyelitis, diphtheria and tetanus, have largely been kept under control by the use of vaccines. For the major epidemics HIV/AIDS, malaria and hepatitis C, no vaccines are available yet. Based on a symposium on vaccinations that took place on 8 November 2010, the working group revised the Leopoldina statements and recommendations from the year 2008.
Among other things, the report dealt with the following points:
- The current state of biomedical research and research into the development of new vaccines
- Authorization procedures and requirements, and vaccination recommendations
- Effectiveness and cost/benefit assessment of vaccinations
- The tasks and interests of science, politics and industry
- The mission and interests of science, politics and industry
- Knowledge and attitudes regarding infections and vaccinations in the population
Institution
- National Academy of Sciences Leopoldina
Spokespersons of the Working Group
- Prof. Dr. Stefan H. E. Kaufmann ML, Max-Planck-Institut für Infektionsbiologie Berlin
- Prof. Dr. Jörg Hacker ML, President of the Leopoldina
Members of the Working Group
- PD Dr. Cornelia Betsch, Universität Erfurt, Center for Empirical Research in Economics and Behavioral Science
- Prof. Dr. Klaus Cichutek, Paul-Ehrlich-Institut, Bundesinstitut für Impfstoffe und biomedizinische Arzneimittel
- Prof. Dr. Werner Goebel ML, Max-von-Pettenkofer-Institut für Hygiene und Medizinische Mikrobiologie, Ludwig-Maximilians-Universität München
- Prof. Dr. Hans-Dieter Klenk ML, Institut für Virologie, Philipps-Universität Marburg
- Prof. Dr. Gérard Krause, Abteilungsleiter Epidemiologie, Helmholtz-Zentrum für Infektionsforschung, Braunschweig
- Prof. Dr. Anja Mehnert, Department für Psychische Gesundheit, Selbständige Abteilung Medizinische Psychologie und Medizinische Soziologie, Sektion Psychosoziale Onkologie, Universitätsklinikum Leipzig
- Prof. Dr Thomas Mertens, Institut für Virologie, Universitätsklinikum Ulm
- Prof. Dr. Thomas C. Mettenleiter ML, Friedrich-Löffler-Institut, Bundesforschungsinstitut für Tiergesundheit
- Prof. Dr. Andreas Radbruch ML, Deutsches Zentrum für Rheumatische Erkrankungen
- Dr. Klaus Stöhr, Basel
- Dr. Ole Wichmann, Fachgruppe Impfprävention am Robert Koch Institut, Berlin
- Prof. Dr. Lothar-Heinz Wieler ML, Präsident Robert-Koch-Institut, Berlin
